MIEČYS - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 6,798,817 | 7,231,250 | 6,756,765 | 6,617,897 | 7,840,689 | 8,534,695 | 9,203,858 | 9,772,799 |
| Profit before tax | 165,893 | 220,386 | 327,263 | 171,394 | 257,705 | 478,746 | 677,815 | 988,259 |
| Net profit | 139,056 | 181,281 | 270,082 | 141,218 | 218,666 | 399,192 | 565,348 | 825,545 |
| Equity | 3,060,375 | 3,241,656 | 3,341,738 | 2,882,955 | 3,001,621 | 3,200,813 | 3,567,420 | 4,192,964 |
| Liabilities | 2,094,238 | 2,048,040 | 1,753,659 | 1,278,324 | 1,495,320 | 1,467,307 | 1,227,150 | 1,676,917 |
| Non-current assets | 140,704 | 122,524 | 94,118 | 75,810 | 74,015 | 108,013 | 163,908 | 209,052 |
| Current assets | 5,014,405 | 5,187,236 | 5,017,875 | 4,107,030 | 4,433,557 | 4,567,410 | 4,630,392 | 5,668,927 |
| Total assets | 5,155,109 | 5,309,760 | 5,111,993 | 4,182,840 | 4,507,572 | 4,675,423 | 4,794,300 | 5,877,979 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 659,931 | 773,104 | 748,984 |
| Social insurance contributions | - | - | - | - | - | 238,224 | 230,583 | 221,973 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -4.5% | +6.4% | -6.6% | -2.1% | +18.5% | +8.9% | +7.8% | +6.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 2.7% | 3.4% | 5.3% | 3.4% | 4.9% | 8.5% | 11.8% | 14.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 4.5% | 5.6% | 8.1% | 4.9% | 7.3% | 12.5% | 15.8% | 19.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 2.0% | 2.5% | 4.0% | 2.1% | 2.8% | 4.7% | 6.1% | 8.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 2.4% | 3.0% | 4.8% | 2.6% | 3.3% | 5.6% | 7.4% | 10.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.7 | 0.6 | 0.5 | 0.4 | 0.5 | 0.5 | 0.3 | 0.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 223,523 | 276,353 | 285,497 | 284,641 | 328,980 | 377,921 | 436,547 | 486,613 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
MIEČYS - Social security debts
The company had no debts to Sodra
MIEČYS - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-01-29 | 2026-01-29 | 4.57 |
| 2026-01-17 | 2026-01-23 | 4.57 |
| 2025-08-01 | 2025-08-08 | 7.25 |
| 2025-06-28 | 2025-07-20 | 5.88 |
| 2025-07-10 | 2025-07-20 | 1904.1 |
| 2025-06-19 | 2025-06-25 | 5.88 |
| 2025-01-17 | 2025-01-23 | 70.16 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
MIECYS, UAB (code 144721095) is a private limited liability company operating in the wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, the company generated revenue of €9.77M and net profit of €825.5K, corresponding to a profit margin of 8.4%. Revenue increased by 6.2% year on year and by 14.5% over two years. The profit trend was also positive, rising from €399.2K in 2023 to €565.3K in 2024 and €825.5K in 2025. The balance sheet strengthened over the period: total assets reached €5.88M in 2025, equity €4.19M and liabilities €1.68M. Key ratios for 2025 indicate solid profitability and balance sheet structure, with ROE at 19.7%, ROA at 14.0%, debt-to-equity at 0.40 and an equity ratio of 71.3%. Asset turnover stood at 1.66x. Revenue per employee was €488.6K, while profit per employee was €41.3K, indicating efficient operations.